SPIROCYCLIC DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
申请人:DAC S.r.l.
公开号:EP2279187A1
公开(公告)日:2011-02-02
[EN] SPIROCYCLIC DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] DÉRIVÉS SPIROCYCLIQUES SERVANT D'INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
申请人:DAC SRL
公开号:WO2009127609A1
公开(公告)日:2009-10-22
This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C=R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
Synthesis and derivatisation of a novel spiro[1-benzofuran-2,4′-piperidin]-3-one scaffold
作者:Rowan A. Wilson、Lai Chan、Robin Wood、Richard C. D. Brown
DOI:10.1039/b507339a
日期:——
The synthesis of a novel spiro[1-benzofuran-2,4â²-piperidin]-3-one scaffold 6 has been achieved in five steps with an overall yield of 47%. The versatility of the spiropiperidine scaffold in the context of library synthesis is exemplified by selective and sequential derivatisation of the amino and aryl bromide functional groups, including the development of multi-step telescope reaction matrices.